/
Matthias Guckenberger - SBRT for stage I NSCLC
50
Stereotactic ablative radiotherapy versus lobectomy for operable
stage I non-small-cell lung cancer: a pooled analysis of two
randomised trials
Chang
Lancet Oncol 2015
Higher rates of adverse events after surgery
No significant differences in recurrence pattern
(Improved) at least equivalent OS